Your institution may have access to this item. Find your institution then sign in to continue.
Title
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.
Authors
Takayama, T; Sekine, T; Makuuchi, M; Yamasaki, S; Kosuge, T; Yamamoto, J; Shimada, K; Sakamoto, M; Hirohashi, S; Ohashi, Y; Kakizoe, T
Abstract
Postsurgical recurrence of hepatocellular carcinoma (HCC) is frequent and fatal. Adoptive immunotherapy is active against HCC. We assessed whether postoperative immunotherapy could lower the frequency of recurrence.